March Altus Capital Management LP - Q1 2014 holdings

$311 Million is the total value of March Altus Capital Management LP's 28 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was - .

 Value Shares↓ Weighting
UTHR NewUNITED THERAPEUTICS CORP DEL$15,677,000166,725
+100.0%
5.03%
PODD NewINSULET CORP$12,837,000270,717
+100.0%
4.12%
BIIB NewBIOGEN IDEC INC$11,310,00036,976
+100.0%
3.63%
ZTS NewZOETIS INCcl a$10,440,000360,761
+100.0%
3.35%
INCY NewINCYTE CORP$9,751,000182,192
+100.0%
3.13%
LMNX NewLUMINEX CORP DEL$9,090,000501,923
+100.0%
2.92%
NUVA NewNUVASIVE INC$6,287,000163,675
+100.0%
2.02%
FURX NewFURIEX PHARMACEUTICALS INC$6,087,00069,960
+100.0%
1.95%
XON NewINTREXON CORP$5,864,000223,037
+100.0%
1.88%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEXCOM INC12Q3 201614.4%
LILLY ELI & CO12Q3 201620.0%
ALEXION PHARMACEUTICALS INC11Q3 201615.1%
MALLINCKRODT PUB LTD CO8Q3 20157.0%
UNITED THERAPEUTICS CORP DEL7Q3 201511.7%
REGENERON PHARMACEUTICALS7Q3 201614.6%
UNIVERSAL HLTH SVCS INC7Q2 201512.1%
ZOETIS INC7Q3 20165.2%
INCYTE CORP6Q4 201514.7%
EDWARDS LIFESCIENCES CORP5Q3 201628.5%

View March Altus Capital Management LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2016-11-07
13F-HR2016-07-27
13F-HR2016-05-12
13F-HR2016-02-16
13F-HR2015-11-16
13F-HR2015-08-14
13F-HR2015-05-15
13F-HR2015-02-17
13F-HR2014-11-14
13F-HR2014-08-14

View March Altus Capital Management LP's complete filings history.

Compare quarters

Export March Altus Capital Management LP's holdings